← Analysis page  ·  Joseph Carlson hub  ·  Research hub

Actionable insights — The Best Stock To Buy During The "AI Slowdown"

Not that he likes Meta, but the tests behind it: who actually benefits if an industry is forced to spend less, how to read a market leader's call for regulation, how to find a position that wins under both outcomes of a debate, and how to discount a scary anecdote before it moves your book.
2026-SEP-14 · Joseph Carlson After Hours · Joseph Carlson · ▶ Watch · full analysis · transcript
How to read this page: each insight is a reusable procedure — a screen, a diagnostic question, or a structural test you can re-run on a different company or policy fight later. The boxed line shows how it played out in this episode. Timestamps deep-link into the video.

4:40 1. When an industry's spending might be capped, screen for heavy spend with indirect monetization

The repeatable method
  1. When a cap on spending becomes plausible (regulation, a coordinated pause, a supply shock), list every big spender on that input.
  2. Split them by how the spend earns money: direct (resold or rented — a cloud selling compute) versus indirect (used internally to improve a separate core business).
  3. For direct monetizers, a cap removes revenue along with cost. For indirect monetizers, a cap removes mostly cost — so ask whether the core business still grows without the frontier version of the input.
  4. Check whether the market already penalizes the spend: a flat stock and a low multiple despite strong revenue growth means the capex is being valued as waste.
  5. Model the cap as margin and FCF expansion plus removal of the "unbounded spending" discount, then ask what multiple the business deserves without it.
Here: "What company is spending more money on capex, more money on AI development with less direct revenue from AI than META? Right now, there really isn't one." AMZN has AWS, GOOGL Google Cloud, MSFT Azure — "all of them are renting out their capacity." Meta grows revenue 27% TTM but has been flat all year at a 21 PE; a slowdown "would make the margins and the free cash flow profile improve" and act as "another third party factor reigning him in" 6:16.
Watch for

25:00 2. Read a market leader's call for regulation with the unilateral-action test

The repeatable method
  1. Identify what the leader says the danger is, and what action would reduce it.
  2. Ask whether the leader could take that action alone, today, without legislation. If yes and it hasn't, the stated reason is not the binding reason.
  3. Read the fine print of the ask for competitive conditions — "coordinated," "industry-wide," "without sacrificing commercial advantage." Those clauses reveal the real objective.
  4. Map who the rule would bind: firms ahead of the leader, level with it, or behind it. A rule that mostly freezes the followers is a moat, whatever its motive.
  5. Conclude on effect, not sincerity: a sincere concern that happens to entrench the incumbent should be analyzed as entrenchment.
Here: Anthropic says its models could threaten civilization, yet wants a pace "that won't sacrifice commercial advantage." Carlson: "Why don't you just slow down?… you could do this easily without an act of Congress." The rule would slow Muse, Gemini and xAI, which are "nipping at their heels" — "the regulatory capture will be complete. Every other company trying to catch up will be legally prohibited from catching up" 29:39. "Even if Daario's concerns about AI are sincere… it's completely irrelevant."
Watch for

26:11 3. Match the policy ask to the asker's financial position

The repeatable method
  1. Pull the asker's cash position, committed future spending, and any upcoming financing event (IPO, debt raise, profitability promise to investors).
  2. Place it on its lifecycle: still building share, or at the top and pivoting to monetization? A company at the top wants to cut costs; a challenger wants to spend.
  3. Do the same for the firms the ask would constrain. If the asker is cash-short and the constrained rival is cash-rich, the ask converts the rival's advantage (money) into nothing.
  4. Note the timing relative to the financing event — an ask that flatters margins right before a listing deserves extra scrutiny.
Here: Anthropic has "over half a trillion dollars in spending commitments," told investors it will be "profitable for the second straight quarter" (FT), and has an IPO ahead: "We need to show healthy margins, good cash flow." Its enterprise share is already won — "what they're focused on now is monetization." Meanwhile META "is flush with cash… Zuckerberg can fund the growth of AI endlessly. And Daario knows that." So Anthropic, "which is short on cash, needs to slow down anyway" 30:46.
Watch for

6:57 4. Find the name that wins under both outcomes of an unresolved debate

The repeatable method
  1. Name the binary the market is arguing about (here: does the core technology commoditize or not?).
  2. For each outcome, ask where the profit pool goes. Commoditization pushes value to the complements — distribution, attention, data, commerce. Non-commoditization keeps value with whoever owns the scarce asset.
  3. Look for a company that owns the complement and keeps a credible, good-enough version of the scarce asset (close to the frontier, not at it).
  4. Contrast it with names exposed to one branch only: pure producers of the scarce asset (lose if it commoditizes) and pure renters of it (lose if it doesn't).
  5. Re-read spending that looks reckless in that light: if the spend buys the second-branch insurance, it reduces risk rather than adding it.
Here: via Colossus — if AI commoditizes, "Anthropic and OpenAI go to zero" (he calls that an exaggeration) and value accrues "to the complements of meta… distribution, attention, personalization and commerce"; if not, Zuckerberg "is not in his competitor's prison the same way that Apple's been. AAPL has no AI for themselves" 7:26. Meta only has to "remain within 6 months of the frontier." "Heads, he wins, tails, he wins… what Mark Zuckerberg's doing has reduced risk in Meta."
Watch for

15:48 5. Judge capital allocation by the record of platform transitions, not by the current spend

The repeatable method
  1. List every platform shift the company has faced and what the consensus predicted each time (mobile, competitor features, scandals, OS privacy changes, antitrust).
  2. Score the outcome: did the company end each period with a stronger position than it started with?
  3. Check governance: can management make bold reversals quickly? A founder with voting control can reorganize in a quarter; a hired CEO usually can't.
  4. Measure the latest pivot's speed with dated facts (reorg, key hires, acquisitions, time to a competitive product).
  5. Only then weigh the "bad capital allocator" narrative — isolated mistakes don't outweigh a consistent transition record.
Here: 2013 mobile ads, 2017 Instagram Stories vs Snapchat, 2020 scandal-proof user growth, Reels vs TikTok, ATT circumvented "by rebuilding targeted ads with large AI models," the FTC break-up beaten. The latest pivot: after Llama 4, MSL stood up "within one quarter," the $14.3B Scale AI stake, Alexandr Wang installed 18:58. Why it's possible: "He is the owner… He has the controlling shares."
Watch for

23:14 6. Before a scare story moves your book, check the setup and the opportunity cost

The repeatable method
  1. Find the one or two anecdotes the scare narrative keeps repeating.
  2. Read the conditions: what access, permissions and oversight did the system have? A failure under no monitoring is a containment failure, not evidence of inherent behaviour.
  3. Test the analogy used to frame the risk. Does the comparison share the original's purpose (a weapons programme) or just its scale?
  4. Price the cost of the proposed remedy using the advocate's own benefit claims — if the technology delivers large benefits sooner, delay has a quantifiable cost too.
  5. Separate the price move (AI stocks sold off) from the probability the remedy is enacted.
Here: the Hugging Face agent swarm was given "unprecedented level of access, terminal access, huge amounts of leeway, and essentially no monitoring… This is a containment issue." The Manhattan Project "was explicitly a weapons producing project"; AI is closer to the internet 10:25. And the essay's own claim that AI "could cure most major diseases in the next 5 to 10 years" means "you're sacrificing all the people that will die of those diseases if you slow it down" 22:43. Meanwhile ASML and NVDA fell on the narrative alone.
Watch for

33:12 7. Look at the payoff distribution before buying a launch

The repeatable method
  1. For any freshly launched speculative token or hype asset, pull the on-chain (or order-flow) winners-and-losers breakdown.
  2. Compare the number of losing buyers to the number of winning wallets, and the concentration of the gains.
  3. If a handful of early wallets capture most of the gains from a large crowd of late buyers, the structure is a transfer, not an investment — no thesis changes that.
Here: the Hunter Biden laptop memecoin fell from ~$190 to under $2 within minutes; ~80% of buyers lost money — 726 lost $1k–10k, 112 lost $10k–100k, two lost $100k–1M — while "just 10 wallets made between a 100,000 and 1 million." "You have a tiny fraction that makes a bunch of money by taking the money from the other people."
Watch for

Methods distilled from the public YouTube video (transcript in transcript.txt) for personal study. Not investment advice. © Joseph Carlson for source material.